Mohammad Yawar Yakoob, MBBS; Yasir Pervez Khan, MBBS; Zulfiqar Ahmed Bhutta, MB, BS, PhD, FRCP, FRCPCH, FCPS, FAAP
快樂小藥師
- Oct 03 Sun 2010 06:18
[Expert Review of Obstetrics & Gynecology]Maternal Mineral and Vitamin Supplementation in Pregnancy
- Oct 02 Sat 2010 06:39
[AJHP]Dosing guidelines, not protocols, for managing warfarin therapy
Ann K. WittKoWSKy, SARAh A. SpinleR, WilliAm dAgeR, michAel p. gulSeth, And edith A. nuteScu
- Oct 01 Fri 2010 07:21
各種顏色的藥水
- Sep 30 Thu 2010 07:05
革蘭氏染色法 Gram staining
此種染色法由丹麥微生物學家Hans Christian Gram 於西元1884 年所創, 是最常用的細菌鑑別染色法。步驟如下:
- Sep 29 Wed 2010 08:00
Glucagon signaling pathway
- Sep 29 Wed 2010 06:30
洗腎患者與藥物引起之高血鉀
- Sep 28 Tue 2010 06:53
[藥物介紹]glucagen
- Sep 27 Mon 2010 06:41
[Medscape] FDA Approves Oral Contraceptive Containing Folate FDA核准含有葉酸的口服避孕藥
- Sep 26 Sun 2010 09:54
學習,不會因為你所在的地方而有所改變
這一篇,是寫給貓貓蝙蝠俠看的.........還有你們
- Sep 25 Sat 2010 07:44
落建各種噴頭實驗
- Sep 24 Fri 2010 07:40
[Medscape]Fingolimod Receives FDA Approval as First Oral MS Treatment
September 22, 2010 — The US Food and Drug Administration (FDA) today announced approval of fingolimod (Gilenya, Novartis), the first of the long-anticipated oral treatments for multiple sclerosis (MS). Fingolimod is approved to reduce relapses and delay disability progression in patients with relapsing forms of MS, an FDA release notes.
- Sep 23 Thu 2010 07:21
到處都是加強錠,到底加強到哪邊?
- Sep 22 Wed 2010 13:57
kindle........請加油
kindle新款繼續上市,我還以為要停產了,當初幸好沒有為了abx guide衝動給他買下去,不然我就是冤大頭了:
- Sep 22 Wed 2010 09:29
常見的藥物血中濃度監測範圍
備忘而已:
- Sep 21 Tue 2010 06:29
保能痔注入軟膏(Borraginol)
- Sep 20 Mon 2010 06:56
[WebMD]Flu Vaccine FAQ 流感疫苗常見問答集
To answer frequenly asked questions about the flu vaccine for the 2009-2010 season, WebMD speaks with CDC flu expert William Atkinson, MD, MPH.
- Sep 19 Sun 2010 07:43
Spiriva respimat 使用簡介
- Sep 18 Sat 2010 07:12
[US pharmacist] The Fungus Among Us: An Antifungal Review
Jamekia N. Owens, PharmD
Community Practitioner
Bessemer, Alabama
Jessica W. Skelley, PharmD
Pharmacy Resident
Jefferson County Health Department
Samford University
McWhorter School of Pharmacy
Birmingham, Alabama
Jeffrey A. Kyle, PharmD, BCPS
Assistant Professor of Pharmacy Practice
Samford University
McWhorter School of Pharmacy
Birmingham, Alabama
8/19/2010
US Pharm. 2010;35(8):44-56
- Sep 17 Fri 2010 07:19
[WebMD]Supplementation of Maternal Milk With Docosahexanoic Acid is Beneficial for Very Premature Infants 母親補充二十二碳六烯酸(DHA)對極早產嬰兒有所幫助
- Sep 16 Thu 2010 09:05
如果你的parallels裡面的windows程式會出現亂碼
其實這是因為安裝時parallels會預設將妳的語言改成英文,但是部分程式是直接讀取中文的字集,就會變成這樣,這類的狀況最常發生在直接購買英文版parallels的人身上。
處理方式很簡單:
- Sep 16 Thu 2010 08:35
[Medscape Cardiology] Warfarin and Cranberry Juice: Time to Lose the Warnings?
Expert Interview With Jack E. Ansell, MD
- Sep 15 Wed 2010 06:52
[FDA Emergency Preparedness] Safe Drug Use After a Natural Disaster
The Center for Drug Evaluation and Research (CDER) at the FDA offers the following information on the use of drugs that have been potentially affected by fire, flooding or unsafe water and the use of temperature-sensitive drug products when refrigeration is temporarily unavailable.
- Sep 14 Tue 2010 06:55
No Benefit from Intravenous Alteplase When Given After 4.5 Hours of Stroke Onset
No Benefit from Intravenous Alteplase When Given After 4.5 Hours of Stroke Onset
- Sep 13 Mon 2010 06:55
[Nature Medicine]Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy
• Carlo Viscomi, Alberto B Burlina, Imad Dweikat, Mario Savoiardo, Costanza Lamperti, Tatjana Hildebrandt,Valeria Tirantitiranti@istituto-besta.it& Massimo
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a mitochondrial matrix sulfur dioxygenase, leading to failure to detoxify sulfide, a product of intestinal anaerobes and, in trace amounts, tissues. Metronidazole, a bactericide, or N-acetylcysteine, a precursor of sulfide-buffering glutathione, substantially prolonged the lifespan of Ethe1-deficient mice, with the combined treatment being additive. The same dual treatment caused marked clinical improvement in five affected children, with hardly any adverse or side effects.
- Sep 12 Sun 2010 07:52
Degradation of TFPI by neutrophils enhances thrombus formation in large blood vessels
In thrombosis, vessel wall injury exposes subendothelial tissue factor (TF) and releases intracellular nucleic acids to initiate coagulation through the extrinsic (TF-FVIIa) and intrinsic (FXIIa, FXIa and FIXa) pathways, respectively.